Drug Discovery and Target Validation

Model disease with precision. AI-powered microenvironments that replicate cell-cell interactions, extracellular matrix, and biomechanical

forces — at the fidelity that matters.

validated applications

One Platform. Evidence-Based Decisions From Target to Clinic

OC-Plex supports seven distinct decision points in drug discovery and development — reducing model-switching risk and building translational confidence across your entire program.

Supported modalities: Immuno-oncology · Small molecules · ADCs · Biologics · Cell therapy · Biomarker discovery

We combine scalable organ chip(s) with AI to transform drug development.

Engineering

Economical microfluidic chips and perfusion solution that balance complexity and throughput.

Organ Chip Models

Organ-on-chip simulates human pathophysiology & drug response, combined with lab automation to generate massive data.

Computation & AI

Morphology-based phenotypic data combined with multi-omics & AI tools to quantify and predict drug targets and candidates.

Imaging

Multiple cell staining methods and high content imaging analysis to accurately capture 3D morphology.

Back
outreach@xellarbio.com
Viber
WhatsApp
Twitter
Linkedin

Contact Us

Leave us a request and we will contact you soon.